Source:http://linkedlifedata.com/resource/pubmed/id/20388036
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-4-19
|
pubmed:abstractText |
The human immunodeficiency virus (HIV) epidemic has led to an increase in the incidence of tuberculosis globally, particularly in sub-Saharan Africa. Coinfection with HIV leads to difficulties in both the diagnosis and treatment of tuberculosis. Because of the poor performance of sputum smear microscopy in HIV-infected patients, more sensitive tests-such as liquid culture systems, nucleic acid amplification assays, and detection of mycobacterial products in various body fluids-are being investigated. The treatment of coinfected patients requires antituberculosis and antiretroviral drugs to be administered concomitantly; challenges include pill burden and patient compliance, drug interactions, overlapping toxic effects, and immune reconstitution syndrome. Both multidrug-resistant and extensively drug-resistant tuberculosis can spread rapidly among an immunocompromised population, with resulting high mortality rates. Current guidelines recommend starting antiretroviral treatment within a few weeks of antituberculosis therapy for patients with CD4 cell counts <350 cells/microL; however, important questions about the drug regimens and timing of antiretroviral therapy remain. Ongoing trials may answer many of these unresolved questions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1537-6591
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1377-86
|
pubmed:meshHeading |
pubmed-meshheading:20388036-Anti-HIV Agents,
pubmed-meshheading:20388036-Antitubercular Agents,
pubmed-meshheading:20388036-Clinical Trials as Topic,
pubmed-meshheading:20388036-Disease Outbreaks,
pubmed-meshheading:20388036-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:20388036-Guidelines as Topic,
pubmed-meshheading:20388036-HIV Infections,
pubmed-meshheading:20388036-Humans,
pubmed-meshheading:20388036-Tuberculosis
|
pubmed:year |
2010
|
pubmed:articleTitle |
HIV-associated tuberculosis: clinical update.
|
pubmed:affiliation |
Tuberculosis Research Centre, Indian Council of Medical Research, Chennai, India. doctorsoumya@yahoo.com
|
pubmed:publicationType |
Journal Article,
Review
|